In a research report released on Friday, Brean Capital analyst Alan Gould reiterated a Hold rating on shares of Walt Disney (NYSE:DIS), after the entertainment giant …
In a research report released on Tuesday, Brean Capital analyst Mike Burton reiterated a Buy rating on shares of Integrated Device Technology Inc (NASDAQ:IDTI), …
Where do the bulls and the bears stand when it comes to Tesla Motors Inc (NASDAQ:TSLA) and Baidu Inc (ADR) (NASDAQ:BIDU) on the …
Brean Capital analyst Alan Gould is out today with a research note on Walt Disney Co (NYSE:DIS), after UK website Betaville reported that Disney and Twitter …
In a research report published Monday, Brean Capital analyst Jason Wittes reiterated a Buy rating on shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX) with a …
Micron Technology, Inc. (NASDAQ:MU) posted fiscal fourth-quarter results yesterday that exceeded expectations, with a top-line surge and EPS beat.
In a research report released Tuesday, Brean Capital analyst Jason Wittes assumed coverage on shares of Inovio Pharmaceuticals Inc (NASDAQ:INO), with a Buy rating …
Brean Capital analyst Jason Wittes was out with a research report, assuming coverage on shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX), with a Buy rating and price target of …
In a research report published Tuesday, Brean Capital analyst Jason Wittes assumed coverage on shares of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), with a Buy rating and price …
Aerie Pharmaceuticals Inc (NASDAQ:AERI) shares jumped over 50%, after the glaucoma drug company announced positive top-line efficacy results from its Phase III “Mercury 1” …
